Asia Pacific Breast Cancer Screening Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Test Type (Blood Marker Test, Imaging Test, Genetic Test, Immunohistochemistry Test),End User (Hospitals, Diagnostic Centers, Cancer Institutes, Research Laboratories), and Country.
The Asia Pacificbreast cancer screening market was valued at US$ 798.57 million in 2019 and is projected to reach US$ 1,120.77 million by 2027; it is expected to grow at a CAGR of 5.4% from 2020 to 2027.
As per the Centers for Disease Control and Prevention (CDC) definition, breast cancer screening refers tochecking a woman’s breasts for cancer before there are signs or symptoms of the disease. The purpose of screening tests is to discover cancer at an early stage when it can be operated or cured. At times, a screening test detects cancer when it is very small or growingslowly.
India Breast Cancer Screening Market Revenue and Forecast to 2027 (US$ Million)
Get more information on this report :
Market Insights
Increasing Investmentsfor Research in Breast Cancer Management
Increasing research activities is likely to enhance the breast cancer screening market in Asia Pacific. For instance, “Novel combination of serum microRNA for detecting breast cancer in the early stage” was conducted in Japan. Furthermore, the government in Japan has initiated cancer control programs as it is one of the leading cause of death in Japan. Cancer screening programs are carried out throughout the country by the municipalities with the government support.
Additionally, increasing research for early diagnosis of breast cancer is likely to favor the breast cancer screening market in Australia. For instance, in October 2019, a NBCF funded (national breast cancer foundation) researcher Sydney University published theresults of pilot trial of 3D mammography (known as tomosynthesis), as per thestudy, breast cancer detection rates are higher with 3D mammography as compared withthe standard 2D mammography.
Test Type-Based Market Insights
Based on test type,the breast cancer screeningmarket is segmented into imaging test, Immunohistochemistry test, genetic test, and blood marker tests. In 2019,the imaging testsegment held the largest share of the market in 2019; moreoverit is anticipated to register the highest CAGR in the market during the forecast period.
Asia Pacific Breast Cancer Screening Market, by Test Type– 2019and 2027
Get more information on this report :
End User-Based MarketInsights
Based onend user, the breast cancer screeningmarketis further segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019; moreoverit is estimated to register the highest CAGR in the market during the forecast period.
Strategic Insights
Product launches and approvalsarethe commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the breast cancer screeningmarketadopt the expansion, collaboration, and product launch strategies to enlarge customer base acrossthe world.These strategies allow the players to maintain their brand name globally. For instance, in October 2018, GE Healthcare launched a product, namely, the Invenia Automated Breast Ultrasound (ABUS) 2.0 in the US. The device is FDA-approved ultrasound supplemental breast screening technology, specifically designed for detecting cancer in dense breast tissue.
By Test Type
- Blood Marker Test
- Imaging Test
- Genetic Test
- Immunohistochemistry Test
By End User
- Diagnostic Centres
- Hospitals
- Research Laboratories
- Cancer Institutes
By Country
- China
- Japan
- India
- Australia
- South Korea
Company Profiles
- Koninklijke Philips N.V.
- Hologic, Inc.
- Becton, Dickinson and Company
- Myriad Genetics, Inc.
- Siemens Healthcare AG
- Exact Sciences Corporation
- OncoCyte Corporation
- POC Medical Systems
- DanaherCorporation
- General Electric Company
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Breast Cancer Screening Market – By Test Type
1.3.2 Asia Pacific Breast Cancer Screening Market – By End User
1.3.3 Asia Pacific Breast Cancer Screening Market– By Region
2. Breast Cancer Screening Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Breast Cancer Screening – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific
4.3 Expert Opinion
5. Asia Pacific Breast Cancer Screening Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Increasing Investments For Research in Breast Cancer Management
5.1.2 Growing Breast Cancer Prevalence Across Asia Pacific
5.2 Key Market Restraints
5.2.1 High Cost Associated With Breast Cancer Screening
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Agreements And Collaborations For Diagnostic Solutions
5.5 Impact Analysis
6. Breast Cancer Screening Market – Regional Analysis
6.1 Asia Pacific Breast Cancer Screening Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players
7. Breast Cancer Screening Market Analysis – By Test Type
7.1 Overview
7.2 Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)
7.2.1 Asia Pacific Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
7.3 Blood Marker Test
7.3.1 Overview
7.4 Blood Marker Tests: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Imaging Test
7.5.1 Overview
7.5.2 Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
7.6 Genetic Test
7.6.1 Overview
7.6.2 Genetic Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Immunohistochemistry Test
7.7.1 Overview
7.7.2 Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8. Breast Cancer Screening Market – By End User
8.1 Overview
8.2 Breast Cancer Screening Market, by End User, 2019 and 2027 (%)
8.2.1 Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostics Centers
8.4.1 Overview
8.4.2 Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Research Laboratories
8.5.1 Overview
8.6 Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Cancer Institutes
8.7.1 Overview
8.8 Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
9. Breast Cancer Screening Market– Regional Analysis
9.1 Asia Pacific: Breast Cancer Screening Market
9.1.1 Overview
9.1.2 Asia Pacific: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia Pacific: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.4 Asia Pacific: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.5 Asia Pacific: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
9.1.6 China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 China: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.6.3 China: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.7 Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Japan: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.7.3 Japan: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.8 India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 India: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.8.3 India: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.9 South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 South Korea: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.9.3 South Korea: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.10 Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Australia: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.10.3 Australia: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic On Asia Pacific Breast Cancer Screening Market
10.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11. Breast Cancer Screening Market – Key Company Profiles
11.1 General Electric Company
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Siemens Healthineers AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Koninklijke Philips N.V.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Hologic, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 BD
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Myriad Genetics, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Danaher
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. China Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 6. China Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Japan Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. IndiaBreast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 10. IndiaBreast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. South Korea Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 12. South Korea Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Australia Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Australia Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 15. Glossary of Terms, Breast Cancer Screening Market
LIST OF FIGURES
Figure 1. Breast Cancer Screening Market Segmentation
Figure 2. Breast Cancer Screening Segmentation – By Region
Figure 3. Asia Pacific Breast Cancer Screening Market Overview
Figure 4. The Imaging Test Segment Held Largest Share Of Test Type Segment In Breast Cancer Screening Market
Figure 5. India Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific PEST Analysis
Figure 7. Breast Cancer Screening Market Impact Analysis Of Driver And Restraints
Figure 8. Asia Pacific Breast Cancer Screening Market – Revenue Forecast And Analysis – 2019- 2027
Figure 9. Market Positioning Of Key Players In Breast Cancer Screening Market
Figure 10. Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)
Figure 11. Blood Marker Tests: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 12. Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 13. Genetic Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 14. Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Breast Cancer Screening Market, by End User, 2019 and 2027 (%)
Figure 16. Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Asia Pacific: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)
Figure 21. Asia Pacific Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
Figure 22. China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
The List of Companies - Asia Pacific Breast Cancer Screening Market
- Koninklijke Philips N.V.
- Hologic, Inc.
- Becton, Dickinson and Company
- Myriad Genetics, Inc.
- Siemens Healthcare AG
- Exact Sciences Corporation
- OncoCyte Corporation
- POC Medical Systems
- DanaherCorporation
- General Electric Company
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific Breast Cancer Screening Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.